COPE-WEL observational validation trial.

• Research type

  Research Study

• Full title

  COPE-WEL observational validation trial. COPD Exacerbation alert system With urinE anaLysis Clinical validation of the Headstart® Test system for early detection of exacerbations in moderate/severe COPD patients.

• IRAS ID

  266942

• Contact name

  Christopher Brightling

• Contact email

  ceb@le.ac.uk

• Sponsor organisation

  Mologic Ltd

• Duration of Study in the UK

  0 years, 11 months, 29 days

• Research summary

  Patients will be asked to collect and test a daily urine sample using a novel testing system (HeadStart Test system) in addition to answering questions abut their daily COPD symptoms for 6 months.
  In summary, this study aims to validate a novel non-invasive point of care (near-patient) testing system, to allow people with COPD to detect pulmonary exacerbations by measuring urinary biomarkers. If successful, we hope that this will provide patients with an easy to use device, which will empower patients and their caregivers to treat exacerbations at an earlier stage, with potential health and economic benefits.

• REC name

  North West - Greater Manchester South Research Ethics Committee

• REC reference

  19/NW/0519

• Date of REC Opinion

  16 Aug 2019

• REC opinion

  Favourable Opinion